中国急救医学
中國急救醫學
중국급구의학
CHINESE JOURNAL OF CRITICAL CARE MEDICINE
2014年
10期
869-872
,共4页
王玲玲%郭振辉%刘坚%陈蕊%姜巧%孙杰%俞宙%肖飞%熊日成
王玲玲%郭振輝%劉堅%陳蕊%薑巧%孫傑%俞宙%肖飛%熊日成
왕령령%곽진휘%류견%진예%강교%손걸%유주%초비%웅일성
高容量血液滤过( HVHF)%严重脓毒症%肠屏障%肠型脂肪酸结合蛋白( IFABP)%二胺氧化酶( DAO)%D-乳酸
高容量血液濾過( HVHF)%嚴重膿毒癥%腸屏障%腸型脂肪痠結閤蛋白( IFABP)%二胺氧化酶( DAO)%D-乳痠
고용량혈액려과( HVHF)%엄중농독증%장병장%장형지방산결합단백( IFABP)%이알양화매( DAO)%D-유산
High volume hemofiltration(HVHF)%Severe sepsis%Intestinal barrier function%Intestinal fatty acid binding protein(IFABP)%Diamine Oxidase(DAO)%D-lactate
目的:探讨高容量血液滤过( HVHF)对老年严重脓毒症患者肠屏障功能的影响。方法按随机原则将严重脓毒症患者分为常规治疗组31例,联合HVHF组23例,分别于入住ICU当时、第2天、第3天、第7天采集外周血,测定血浆肠型脂肪酸结合蛋白( IFABP)、二胺氧化酶( DAO)、D-乳酸,并记录28 d病死率。结果治疗前两组IFABP、DAO、D-乳酸水平比较差异无统计学意义(P>0.05),治疗后均有所下降,除第3天两组血浆IFABP水平比较差异无统计学意义( P>0.05)外,其余各时间点联合HVHF组较同期常规治疗组各指标均显著下降( P<0.05)。联合HVHF组28 d病死率显著低于常规治疗组(39.1% vs 80.6%, P<0.05)。结论HVHF对老年严重脓毒症患者肠屏障功能具有保护作用,可显著降低病死率,并改善预后。
目的:探討高容量血液濾過( HVHF)對老年嚴重膿毒癥患者腸屏障功能的影響。方法按隨機原則將嚴重膿毒癥患者分為常規治療組31例,聯閤HVHF組23例,分彆于入住ICU噹時、第2天、第3天、第7天採集外週血,測定血漿腸型脂肪痠結閤蛋白( IFABP)、二胺氧化酶( DAO)、D-乳痠,併記錄28 d病死率。結果治療前兩組IFABP、DAO、D-乳痠水平比較差異無統計學意義(P>0.05),治療後均有所下降,除第3天兩組血漿IFABP水平比較差異無統計學意義( P>0.05)外,其餘各時間點聯閤HVHF組較同期常規治療組各指標均顯著下降( P<0.05)。聯閤HVHF組28 d病死率顯著低于常規治療組(39.1% vs 80.6%, P<0.05)。結論HVHF對老年嚴重膿毒癥患者腸屏障功能具有保護作用,可顯著降低病死率,併改善預後。
목적:탐토고용량혈액려과( HVHF)대노년엄중농독증환자장병장공능적영향。방법안수궤원칙장엄중농독증환자분위상규치료조31례,연합HVHF조23례,분별우입주ICU당시、제2천、제3천、제7천채집외주혈,측정혈장장형지방산결합단백( IFABP)、이알양화매( DAO)、D-유산,병기록28 d병사솔。결과치료전량조IFABP、DAO、D-유산수평비교차이무통계학의의(P>0.05),치료후균유소하강,제제3천량조혈장IFABP수평비교차이무통계학의의( P>0.05)외,기여각시간점연합HVHF조교동기상규치료조각지표균현저하강( P<0.05)。연합HVHF조28 d병사솔현저저우상규치료조(39.1% vs 80.6%, P<0.05)。결론HVHF대노년엄중농독증환자장병장공능구유보호작용,가현저강저병사솔,병개선예후。
Objective Tto evaluate the change in intestinal barrier function in patients with severe sepsis during HVHF therapy .Methods Fifty -four patients were randomly divided into the control group ( n =31 ) and the HVHF group ( n =23 ) .Peripheral blood from sepsis patients were routinely collected on day 0, 2, 3, 7 after admission.The levels of IFABP, DAO and D-lactate were measured, and death rate of patients in 28 days were recorded.Results There was no difference between the two groups at baseline .However , compared with the conventional treatment group , the plasma levels of IFABP , DAO and D-lactate of HVHF group after HVHF were significantly decreased except for IFABP on day 3 (P<0.05), and the 28-day mortality was significantly reduced (39.1%vs 80.6%, P <0.05).Conclusion HVHF can protect intestinal barrier function, and reduce the mortality as well as improve clinical outcome in elderly patients with sepsis .